The Safety Profile of Dalfampridine Extended Release in Multiple Sclerosis Clinical Trials. Cornblath DR, Bienen JE, Blight AR Clin Ther. 2012 Apr 11. PMID: 22497693. Abstract CommentRecommendBookmarkWatch